<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>Informa 制药智库 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-25T23:22:52+08:00</updated>
  <subtitle>Pharma Intelligence 致力于为全球主要公司及合同研究机构（CROs) 提供强大的药物研发及市场销售数据独家分析报告，为其研发活动及商业决策提供支持。本平台专注于为分享药物研发／生物科技／医疗器械等领域的前沿咨询及独家分析。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>AI有助于寻找多种抗COVID-19药物，但......</title>
    <updated>2020-11-25T23:02:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/PuEFJdccDdyAplgpapcCBQ</id>
    <link href="https://mp.weixin.qq.com/s/PuEFJdccDdyAplgpapcCBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【要闻】有关阿尔兹海默症药物审批风波</title>
    <updated>2020-11-25T23:02:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/11MkeM3zlu8a-eyHqE98Dg</id>
    <link href="https://mp.weixin.qq.com/s/11MkeM3zlu8a-eyHqE98Dg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>翘首以待的COVID-19疫苗进展：辉瑞和Moderna发布三期试验期中数据及其试验方案</title>
    <updated>2020-11-19T05:29:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/AdLjQSpWyePL8yeh-5P-LA</id>
    <link href="https://mp.weixin.qq.com/s/AdLjQSpWyePL8yeh-5P-LA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新：2020第三季度医药行业交易统计</title>
    <updated>2020-11-19T05:29:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/v9dN6EPS3_I8WcYD7uNKUA</id>
    <link href="https://mp.weixin.qq.com/s/v9dN6EPS3_I8WcYD7uNKUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>COVID-19 疫苗：美国FDA会动用紧急使用权限制优先接种人群吗？</title>
    <updated>2020-11-14T06:51:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/e9Kpeuj83pbkCRDL9kN55A</id>
    <link href="https://mp.weixin.qq.com/s/e9Kpeuj83pbkCRDL9kN55A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>要闻：仿制药批准量五年来首次下降</title>
    <updated>2020-11-14T06:51:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/rIaeCQ-JuFsHb9CstUOp-Q</id>
    <link href="https://mp.weixin.qq.com/s/rIaeCQ-JuFsHb9CstUOp-Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Mirati的KRAS抑制剂在功效方面具有优势，但是。。。</title>
    <updated>2020-11-10T01:02:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/U5IPF4HfP-iCCEDOxYYaMA</id>
    <link href="https://mp.weixin.qq.com/s/U5IPF4HfP-iCCEDOxYYaMA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新消息：Sobi与Apellis达成协议，共同研发罕见病药物</title>
    <updated>2020-11-10T01:02:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-10:/s/tljqVsPpsigaNdVLEORTnw</id>
    <link href="https://mp.weixin.qq.com/s/tljqVsPpsigaNdVLEORTnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>亚洲交易观察：亚洲地区主要的肿瘤合作、授权活动</title>
    <updated>2020-10-31T03:31:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/KJzZj4lj-uVa3MYEQLI3yw</id>
    <link href="https://mp.weixin.qq.com/s/KJzZj4lj-uVa3MYEQLI3yw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>未来治疗罕见先天性和遗传性疾病的方法</title>
    <updated>2020-10-31T03:31:24+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-31:/s/mmLt-5W1W3dVoM2cDtyOag</id>
    <link href="https://mp.weixin.qq.com/s/mmLt-5W1W3dVoM2cDtyOag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>极具潜力的近期上市的生物科技公司</title>
    <updated>2020-10-24T00:29:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-24:/s/JXVKTaEHWZHSCmGZcKnk1A</id>
    <link href="https://mp.weixin.qq.com/s/JXVKTaEHWZHSCmGZcKnk1A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【信息图】Operation Warp Speed — 神速运行！美国高速开发冠状病毒疫苗的计划</title>
    <updated>2020-10-24T00:29:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-24:/s/wXXvqzog8RC3MZXHHQr3hw</id>
    <link href="https://mp.weixin.qq.com/s/wXXvqzog8RC3MZXHHQr3hw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信息图：占据2020新闻头条的肿瘤领域交易</title>
    <updated>2020-10-17T02:06:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-17:/s/1rV70MHmRLBO5YDS7bQSTQ</id>
    <link href="https://mp.weixin.qq.com/s/1rV70MHmRLBO5YDS7bQSTQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>收购新基近一年后：BMS首席医疗官CMO谈研发药物进展，临床试验多样性</title>
    <updated>2020-10-17T02:06:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-17:/s/SthrU5oVKeYuxwSxqh4oNA</id>
    <link href="https://mp.weixin.qq.com/s/SthrU5oVKeYuxwSxqh4oNA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>技术转让摘要： 肿瘤学领域交易集中于CAR-T创新、ADC、和DNA损伤反应</title>
    <updated>2020-10-10T03:37:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-10:/s/7Rp3x8iYHBS4Ccbv7nhlOA</id>
    <link href="https://mp.weixin.qq.com/s/7Rp3x8iYHBS4Ccbv7nhlOA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>超过5亿美元资金在一周内涌入China Bioventures</title>
    <updated>2020-10-10T03:37:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-10:/s/vY73Q-B6raVniCfgfV5Zpg</id>
    <link href="https://mp.weixin.qq.com/s/vY73Q-B6raVniCfgfV5Zpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>用于中枢神经系统疾病的致幻剂：机会解读</title>
    <updated>2020-09-25T16:45:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-25:/s/SuSVPYKruBnvBemf49eM7w</id>
    <link href="https://mp.weixin.qq.com/s/SuSVPYKruBnvBemf49eM7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Datamonitor Healthcare: 数据分析与洞察</title>
    <updated>2020-09-25T16:45:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-25:/s/dCnYZAgJXxRHSjIgnPAz7g</id>
    <link href="https://mp.weixin.qq.com/s/dCnYZAgJXxRHSjIgnPAz7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年度发布的神经病学、心血管和内分泌领域的关键潜在药物</title>
    <updated>2020-09-21T16:55:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-21:/s/YHPeeClEOJoPC4YooVpnMw</id>
    <link href="https://mp.weixin.qq.com/s/YHPeeClEOJoPC4YooVpnMw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>信息图: 2019 年十大畅销药品</title>
    <updated>2020-09-21T16:55:53+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-09-21:/s/LDnQOjNcGcUon20lpA_tig</id>
    <link href="https://mp.weixin.qq.com/s/LDnQOjNcGcUon20lpA_tig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>